These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 15833087

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neurophysiology and neuromodulators.
    Aguggia M, D'Andrea G, Bussone G.
    Neurol Sci; 2007 May; 28 Suppl 2():S97-S100. PubMed ID: 17508189
    [Abstract] [Full Text] [Related]

  • 3. Central neurogenic mechanisms of migraine.
    Welch KM, Barkley GL, Tepley N, Ramadan NM.
    Neurology; 1993 Jun; 43(6 Suppl 3):S21-5. PubMed ID: 8502383
    [Abstract] [Full Text] [Related]

  • 4. Cortical spreading depression and estrogen.
    Eikermann-Haerter K, Kudo C, Moskowitz MA.
    Headache; 2007 Sep; 47 Suppl 2():S79-85. PubMed ID: 17850538
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The concept of migraine as a state of central neuronal hyperexcitability.
    Welch KM, D'Andrea G, Tepley N, Barkley G, Ramadan NM.
    Neurol Clin; 1990 Nov; 8(4):817-28. PubMed ID: 1979655
    [Abstract] [Full Text] [Related]

  • 8. Pathophysiological basis of migraine prophylaxis.
    Galletti F, Cupini LM, Corbelli I, Calabresi P, Sarchielli P.
    Prog Neurobiol; 2009 Oct; 89(2):176-92. PubMed ID: 19654035
    [Abstract] [Full Text] [Related]

  • 9. Neurophysiological features of the migrainous brain.
    Schoenen J.
    Neurol Sci; 2006 May; 27 Suppl 2():S77-81. PubMed ID: 16688634
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Current trends in migraine prophylaxis.
    Ramadan NM.
    Headache; 2007 Apr; 47 Suppl 1():S52-7. PubMed ID: 17425710
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Three-dimensional localization of abnormal EEG activity in migraine: a low resolution electromagnetic tomography (LORETA) study of migraine patients in the pain-free interval.
    Clemens B, Bánk J, Piros P, Bessenyei M, Veto S, Tóth M, Kondákor I.
    Brain Topogr; 2008 Sep; 21(1):36-42. PubMed ID: 18679787
    [Abstract] [Full Text] [Related]

  • 15. Translational imaging studies of cortical spreading depression in experimental models for migraine aura.
    Smith JM, James MF, Fraser JA, Huang CL.
    Expert Rev Neurother; 2008 May; 8(5):759-68. PubMed ID: 18457533
    [Abstract] [Full Text] [Related]

  • 16. Cortical hyperexcitability in migraine patients before and after sodium valproate treatment.
    Bowyer SM, Mason KM, Moran JE, Tepley N, Mitsias PD.
    J Clin Neurophysiol; 2005 May; 22(1):65-7. PubMed ID: 15689715
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic daily cortical spreading depressions suppress spreading depression susceptibility.
    Sukhotinsky I, Dilekoz E, Wang Y, Qin T, Eikermann-Haerter K, Waeber C, Ayata C.
    Cephalalgia; 2011 Dec; 31(16):1601-8. PubMed ID: 22013142
    [Abstract] [Full Text] [Related]

  • 20. Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment.
    Moskowitz MA.
    Funct Neurol; 2007 Dec; 22(3):133-6. PubMed ID: 17925161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.